STOCK TITAN

[Form 4] OmniAb, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

OmniAb, Inc. (OABI) – Form 4 filed 18-Jun-2025

Director Steven Love reported several equity transactions dated 17-Jun-2025. The filing shows a routine mix of RSU vesting, fresh equity grants and the associated increase in directly held common shares.

  • RSU vesting (Code M): 20,000 previously awarded restricted stock units converted into an equal number of common shares. Mr. Love’s direct shareholdings rose to 58,333 shares following the conversion.
  • New RSU grant (Code A): 20,000 RSUs were awarded. These units vest in full on the earlier of OmniAb’s next annual shareholder meeting or the first anniversary of the grant date.
  • New stock option grant (Code A): 40,000 options with a strike price of $1.70 and a 10-year term (expiring 17-Jun-2035) were issued. The option vests in full on the same schedule as the RSUs.

Post-transaction derivative holdings now comprise 46,667 RSUs and 40,000 stock options, while non-derivative ownership stands at 58,333 common shares. No open-market sales were disclosed, indicating that all changes stem from equity compensation and not from dispositions that might pressure the share float.

Because the reported activities involve standard director compensation and do not reflect purchases or sales on the open market, the filing is generally viewed as neutral-to-slightly-positive: it aligns the director’s incentives with shareholders without signaling divestiture. Material financial performance data is not included in this filing.

OmniAb, Inc. (OABI) – Modulo 4 depositato il 18-giu-2025

Il direttore Steven Love ha comunicato diverse operazioni azionarie datate 17-giu-2025. La dichiarazione mostra una combinazione abituale di maturazione di RSU, nuove assegnazioni di azioni e l’aumento conseguente delle azioni ordinarie detenute direttamente.

  • Maturazione RSU (Codice M): 20.000 unità di azioni ristrette precedentemente assegnate sono state convertite in un pari numero di azioni ordinarie. Le azioni detenute direttamente dal Sig. Love sono salite a 58.333 azioni dopo la conversione.
  • Nuova assegnazione RSU (Codice A): Sono state assegnate 20.000 RSU. Queste unità maturano integralmente alla data del prossimo incontro annuale degli azionisti di OmniAb o al primo anniversario della data di assegnazione, a seconda di quale evento si verifichi prima.
  • Nuova assegnazione di stock option (Codice A): Sono state emesse 40.000 opzioni con prezzo di esercizio di $1,70 e durata di 10 anni (scadenza 17-giu-2035). Le opzioni maturano con lo stesso calendario delle RSU.

Al termine delle operazioni, le partecipazioni derivati comprendono ora 46.667 RSU e 40.000 stock option, mentre la proprietà non derivata ammonta a 58.333 azioni ordinarie. Non sono state segnalate vendite sul mercato aperto, il che indica che tutte le variazioni derivano da compensi azionari e non da cessioni che potrebbero influenzare la flottante azionario.

Poiché le attività riportate riguardano una compensazione standard per il direttore e non riflettono acquisti o vendite sul mercato aperto, la dichiarazione è generalmente considerata neutrale o leggermente positiva: allinea gli incentivi del direttore con quelli degli azionisti senza segnalare disinvestimenti. Dati finanziari rilevanti non sono inclusi in questo deposito.

OmniAb, Inc. (OABI) – Formulario 4 presentado el 18-jun-2025

El director Steven Love informó varias transacciones de acciones con fecha 17-jun-2025. La presentación muestra una combinación habitual de consolidación de RSU, nuevas concesiones de acciones y el aumento correspondiente en las acciones comunes directamente poseídas.

  • Consolidación de RSU (Código M): 20,000 unidades de acciones restringidas previamente otorgadas se convirtieron en un número igual de acciones comunes. La participación directa del Sr. Love aumentó a 58,333 acciones tras la conversión.
  • Nueva concesión de RSU (Código A): Se otorgaron 20,000 RSU. Estas unidades se consolidan completamente en la fecha que ocurra primero entre la próxima junta anual de accionistas de OmniAb o el primer aniversario de la fecha de concesión.
  • Nueva concesión de opciones sobre acciones (Código A): Se emitieron 40,000 opciones con un precio de ejercicio de $1.70 y un plazo de 10 años (expiran el 17-jun-2035). La opción se consolida según el mismo calendario que las RSU.

Tras la transacción, las participaciones en derivados comprenden 46,667 RSU y 40,000 opciones sobre acciones, mientras que la propiedad no derivada es de 58,333 acciones comunes. No se divulgaron ventas en el mercado abierto, lo que indica que todos los cambios provienen de compensación en acciones y no de disposiciones que podrían presionar el flotante de acciones.

Dado que las actividades reportadas involucran una compensación estándar para el director y no reflejan compras o ventas en el mercado abierto, la presentación se considera generalmente neutral a ligeramente positiva: alinea los incentivos del director con los accionistas sin indicar desinversiones. No se incluyen datos financieros materiales en esta presentación.

OmniAb, Inc. (OABI) – 2025년 6월 18일 제출된 Form 4

이사 Steven Love는 2025년 6월 17일자로 여러 주식 거래를 보고했습니다. 제출된 내용은 RSU 성숙, 신규 주식 부여 및 직접 보유 보통주 증가의 일반적인 조합을 보여줍니다.

  • RSU 성숙 (코드 M): 이전에 부여된 20,000개의 제한 주식 단위가 동일 수의 보통주로 전환되었습니다. 전환 후 Mr. Love의 직접 보유 주식은 58,333주로 증가했습니다.
  • 신규 RSU 부여 (코드 A): 20,000개의 RSU가 부여되었습니다. 이 단위들은 OmniAb의 다음 연례 주주총회 또는 부여일로부터 1주년 중 먼저 도래하는 날짜에 전액 성숙합니다.
  • 신규 스톡 옵션 부여 (코드 A): 행사가격 $1.70, 만기 10년(2025년 6월 17일 만료)인 40,000개의 옵션이 발행되었습니다. 옵션은 RSU와 동일한 일정에 따라 전액 성숙합니다.

거래 후 파생상품 보유는 46,667 RSU40,000 스톡 옵션으로 구성되며, 비파생 보유는 58,333 보통주입니다. 공개 시장 매도는 보고되지 않아 모든 변동이 주식 보상에서 비롯되었음을 나타내며, 주식 유통량에 압박을 가할 매도는 없었습니다.

보고된 활동은 표준 이사 보상에 해당하며 공개 시장에서의 매매를 반영하지 않으므로, 제출 내용은 일반적으로 중립에서 약간 긍정적으로 간주됩니다: 이는 이사의 인센티브를 주주와 일치시키면서 매도 신호를 보내지 않습니다. 중요한 재무 성과 데이터는 이 제출에 포함되어 있지 않습니다.

OmniAb, Inc. (OABI) – Formulaire 4 déposé le 18 juin 2025

Le directeur Steven Love a déclaré plusieurs transactions sur actions datées du 17 juin 2025. Le dépôt montre une combinaison habituelle de vesting de RSU, de nouvelles attributions d’actions et l’augmentation associée des actions ordinaires détenues directement.

  • Vesting de RSU (Code M) : 20 000 unités d’actions restreintes précédemment attribuées ont été converties en un nombre égal d’actions ordinaires. La détention directe de M. Love est passée à 58 333 actions après conversion.
  • Nouvelle attribution de RSU (Code A) : 20 000 RSU ont été attribuées. Ces unités vestent intégralement à la date la plus proche entre la prochaine assemblée annuelle des actionnaires d’OmniAb ou le premier anniversaire de la date d’attribution.
  • Nouvelle attribution d’options d’achat d’actions (Code A) : 40 000 options avec un prix d’exercice de 1,70 $ et une durée de 10 ans (expiration le 17 juin 2035) ont été émises. L’option vest selon le même calendrier que les RSU.

Après la transaction, les détentions dérivées comprennent désormais 46 667 RSU et 40 000 options d’achat, tandis que la détention non dérivée s’élève à 58 333 actions ordinaires. Aucune vente sur le marché ouvert n’a été divulguée, ce qui indique que tous les changements proviennent d’une rémunération en actions et non de cessions susceptibles de peser sur le flottant des actions.

Comme les activités déclarées concernent une rémunération standard des administrateurs et ne reflètent pas d’achats ou de ventes sur le marché ouvert, le dépôt est généralement considéré comme neutre à légèrement positif : il aligne les incitations du directeur avec celles des actionnaires sans signaler de désinvestissement. Les données financières importantes ne sont pas incluses dans ce dépôt.

OmniAb, Inc. (OABI) – Form 4 eingereicht am 18. Juni 2025

Der Direktor Steven Love meldete mehrere Aktiengeschäfte vom 17. Juni 2025. Die Meldung zeigt eine übliche Kombination aus RSU-Vesting, neuen Aktienzuteilungen und der damit verbundenen Erhöhung der direkt gehaltenen Stammaktien.

  • RSU-Vesting (Code M): 20.000 zuvor gewährte Restricted Stock Units wurden in die gleiche Anzahl von Stammaktien umgewandelt. Nach der Umwandlung stieg der direkte Aktienbesitz von Herrn Love auf 58.333 Aktien.
  • Neue RSU-Zuteilung (Code A): 20.000 RSUs wurden gewährt. Diese Einheiten vesten vollständig zum früheren Zeitpunkt der nächsten Jahreshauptversammlung von OmniAb oder zum ersten Jahrestag des Zuteilungsdatums.
  • Neue Aktienoptionszuteilung (Code A): 40.000 Optionen mit einem Ausübungspreis von $1,70 und einer Laufzeit von 10 Jahren (Ablauf 17. Juni 2035) wurden ausgegeben. Die Optionen vesten nach dem gleichen Zeitplan wie die RSUs.

Nach der Transaktion umfassen die Derivatbestände nun 46.667 RSUs und 40.000 Aktienoptionen, während der nicht-derivative Besitz bei 58.333 Stammaktien liegt. Es wurden keine Verkäufe am offenen Markt gemeldet, was darauf hinweist, dass alle Änderungen aus Aktienvergütungen resultieren und nicht aus Veräußerungen, die den Streubesitz belasten könnten.

Da die gemeldeten Aktivitäten eine Standardvergütung für Direktoren betreffen und keine Käufe oder Verkäufe am offenen Markt widerspiegeln, wird die Meldung allgemein als neutral bis leicht positiv eingestuft: Sie richtet die Anreize des Direktors mit denen der Aktionäre aus, ohne eine Veräußerung anzudeuten. Wesentliche finanzielle Leistungsdaten sind in dieser Meldung nicht enthalten.

Positive
  • No open-market sales: all transactions were acquisitions or grants, avoiding negative selling signal.
  • Alignment of interests: new RSUs and options increase the director’s equity stake, potentially enhancing shareholder alignment.
Negative
  • None.

Insights

TL;DR: Routine equity awards; no open-market selling; limited market impact.

The Form 4 indicates normal annual compensation mechanics. 20 k RSUs vested and converted, increasing common shares held. Concurrently, Mr. Love received 20 k new RSUs and 40 k options at a $1.70 strike, all vesting within roughly one year. The absence of dispositions suggests no bearish signal; however, the volume is small relative to OmniAb’s float, so trading impact should be minimal.

TL;DR: Compensation structure aligns director interests; standard one-year vesting.

The grants use short-horizon vesting tied to the next AGM, consistent with prevailing governance best practices that promote director alignment without long deferral. Option pricing at $1.70 keeps incentives out-of-the-money unless the stock appreciates, reinforcing pay-for-performance. No red flags arise from timing or structure.

OmniAb, Inc. (OABI) – Modulo 4 depositato il 18-giu-2025

Il direttore Steven Love ha comunicato diverse operazioni azionarie datate 17-giu-2025. La dichiarazione mostra una combinazione abituale di maturazione di RSU, nuove assegnazioni di azioni e l’aumento conseguente delle azioni ordinarie detenute direttamente.

  • Maturazione RSU (Codice M): 20.000 unità di azioni ristrette precedentemente assegnate sono state convertite in un pari numero di azioni ordinarie. Le azioni detenute direttamente dal Sig. Love sono salite a 58.333 azioni dopo la conversione.
  • Nuova assegnazione RSU (Codice A): Sono state assegnate 20.000 RSU. Queste unità maturano integralmente alla data del prossimo incontro annuale degli azionisti di OmniAb o al primo anniversario della data di assegnazione, a seconda di quale evento si verifichi prima.
  • Nuova assegnazione di stock option (Codice A): Sono state emesse 40.000 opzioni con prezzo di esercizio di $1,70 e durata di 10 anni (scadenza 17-giu-2035). Le opzioni maturano con lo stesso calendario delle RSU.

Al termine delle operazioni, le partecipazioni derivati comprendono ora 46.667 RSU e 40.000 stock option, mentre la proprietà non derivata ammonta a 58.333 azioni ordinarie. Non sono state segnalate vendite sul mercato aperto, il che indica che tutte le variazioni derivano da compensi azionari e non da cessioni che potrebbero influenzare la flottante azionario.

Poiché le attività riportate riguardano una compensazione standard per il direttore e non riflettono acquisti o vendite sul mercato aperto, la dichiarazione è generalmente considerata neutrale o leggermente positiva: allinea gli incentivi del direttore con quelli degli azionisti senza segnalare disinvestimenti. Dati finanziari rilevanti non sono inclusi in questo deposito.

OmniAb, Inc. (OABI) – Formulario 4 presentado el 18-jun-2025

El director Steven Love informó varias transacciones de acciones con fecha 17-jun-2025. La presentación muestra una combinación habitual de consolidación de RSU, nuevas concesiones de acciones y el aumento correspondiente en las acciones comunes directamente poseídas.

  • Consolidación de RSU (Código M): 20,000 unidades de acciones restringidas previamente otorgadas se convirtieron en un número igual de acciones comunes. La participación directa del Sr. Love aumentó a 58,333 acciones tras la conversión.
  • Nueva concesión de RSU (Código A): Se otorgaron 20,000 RSU. Estas unidades se consolidan completamente en la fecha que ocurra primero entre la próxima junta anual de accionistas de OmniAb o el primer aniversario de la fecha de concesión.
  • Nueva concesión de opciones sobre acciones (Código A): Se emitieron 40,000 opciones con un precio de ejercicio de $1.70 y un plazo de 10 años (expiran el 17-jun-2035). La opción se consolida según el mismo calendario que las RSU.

Tras la transacción, las participaciones en derivados comprenden 46,667 RSU y 40,000 opciones sobre acciones, mientras que la propiedad no derivada es de 58,333 acciones comunes. No se divulgaron ventas en el mercado abierto, lo que indica que todos los cambios provienen de compensación en acciones y no de disposiciones que podrían presionar el flotante de acciones.

Dado que las actividades reportadas involucran una compensación estándar para el director y no reflejan compras o ventas en el mercado abierto, la presentación se considera generalmente neutral a ligeramente positiva: alinea los incentivos del director con los accionistas sin indicar desinversiones. No se incluyen datos financieros materiales en esta presentación.

OmniAb, Inc. (OABI) – 2025년 6월 18일 제출된 Form 4

이사 Steven Love는 2025년 6월 17일자로 여러 주식 거래를 보고했습니다. 제출된 내용은 RSU 성숙, 신규 주식 부여 및 직접 보유 보통주 증가의 일반적인 조합을 보여줍니다.

  • RSU 성숙 (코드 M): 이전에 부여된 20,000개의 제한 주식 단위가 동일 수의 보통주로 전환되었습니다. 전환 후 Mr. Love의 직접 보유 주식은 58,333주로 증가했습니다.
  • 신규 RSU 부여 (코드 A): 20,000개의 RSU가 부여되었습니다. 이 단위들은 OmniAb의 다음 연례 주주총회 또는 부여일로부터 1주년 중 먼저 도래하는 날짜에 전액 성숙합니다.
  • 신규 스톡 옵션 부여 (코드 A): 행사가격 $1.70, 만기 10년(2025년 6월 17일 만료)인 40,000개의 옵션이 발행되었습니다. 옵션은 RSU와 동일한 일정에 따라 전액 성숙합니다.

거래 후 파생상품 보유는 46,667 RSU40,000 스톡 옵션으로 구성되며, 비파생 보유는 58,333 보통주입니다. 공개 시장 매도는 보고되지 않아 모든 변동이 주식 보상에서 비롯되었음을 나타내며, 주식 유통량에 압박을 가할 매도는 없었습니다.

보고된 활동은 표준 이사 보상에 해당하며 공개 시장에서의 매매를 반영하지 않으므로, 제출 내용은 일반적으로 중립에서 약간 긍정적으로 간주됩니다: 이는 이사의 인센티브를 주주와 일치시키면서 매도 신호를 보내지 않습니다. 중요한 재무 성과 데이터는 이 제출에 포함되어 있지 않습니다.

OmniAb, Inc. (OABI) – Formulaire 4 déposé le 18 juin 2025

Le directeur Steven Love a déclaré plusieurs transactions sur actions datées du 17 juin 2025. Le dépôt montre une combinaison habituelle de vesting de RSU, de nouvelles attributions d’actions et l’augmentation associée des actions ordinaires détenues directement.

  • Vesting de RSU (Code M) : 20 000 unités d’actions restreintes précédemment attribuées ont été converties en un nombre égal d’actions ordinaires. La détention directe de M. Love est passée à 58 333 actions après conversion.
  • Nouvelle attribution de RSU (Code A) : 20 000 RSU ont été attribuées. Ces unités vestent intégralement à la date la plus proche entre la prochaine assemblée annuelle des actionnaires d’OmniAb ou le premier anniversaire de la date d’attribution.
  • Nouvelle attribution d’options d’achat d’actions (Code A) : 40 000 options avec un prix d’exercice de 1,70 $ et une durée de 10 ans (expiration le 17 juin 2035) ont été émises. L’option vest selon le même calendrier que les RSU.

Après la transaction, les détentions dérivées comprennent désormais 46 667 RSU et 40 000 options d’achat, tandis que la détention non dérivée s’élève à 58 333 actions ordinaires. Aucune vente sur le marché ouvert n’a été divulguée, ce qui indique que tous les changements proviennent d’une rémunération en actions et non de cessions susceptibles de peser sur le flottant des actions.

Comme les activités déclarées concernent une rémunération standard des administrateurs et ne reflètent pas d’achats ou de ventes sur le marché ouvert, le dépôt est généralement considéré comme neutre à légèrement positif : il aligne les incitations du directeur avec celles des actionnaires sans signaler de désinvestissement. Les données financières importantes ne sont pas incluses dans ce dépôt.

OmniAb, Inc. (OABI) – Form 4 eingereicht am 18. Juni 2025

Der Direktor Steven Love meldete mehrere Aktiengeschäfte vom 17. Juni 2025. Die Meldung zeigt eine übliche Kombination aus RSU-Vesting, neuen Aktienzuteilungen und der damit verbundenen Erhöhung der direkt gehaltenen Stammaktien.

  • RSU-Vesting (Code M): 20.000 zuvor gewährte Restricted Stock Units wurden in die gleiche Anzahl von Stammaktien umgewandelt. Nach der Umwandlung stieg der direkte Aktienbesitz von Herrn Love auf 58.333 Aktien.
  • Neue RSU-Zuteilung (Code A): 20.000 RSUs wurden gewährt. Diese Einheiten vesten vollständig zum früheren Zeitpunkt der nächsten Jahreshauptversammlung von OmniAb oder zum ersten Jahrestag des Zuteilungsdatums.
  • Neue Aktienoptionszuteilung (Code A): 40.000 Optionen mit einem Ausübungspreis von $1,70 und einer Laufzeit von 10 Jahren (Ablauf 17. Juni 2035) wurden ausgegeben. Die Optionen vesten nach dem gleichen Zeitplan wie die RSUs.

Nach der Transaktion umfassen die Derivatbestände nun 46.667 RSUs und 40.000 Aktienoptionen, während der nicht-derivative Besitz bei 58.333 Stammaktien liegt. Es wurden keine Verkäufe am offenen Markt gemeldet, was darauf hinweist, dass alle Änderungen aus Aktienvergütungen resultieren und nicht aus Veräußerungen, die den Streubesitz belasten könnten.

Da die gemeldeten Aktivitäten eine Standardvergütung für Direktoren betreffen und keine Käufe oder Verkäufe am offenen Markt widerspiegeln, wird die Meldung allgemein als neutral bis leicht positiv eingestuft: Sie richtet die Anreize des Direktors mit denen der Aktionäre aus, ohne eine Veräußerung anzudeuten. Wesentliche finanzielle Leistungsdaten sind in dieser Meldung nicht enthalten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Love Steven

(Last) (First) (Middle)
5980 HORTON STREET, STE 600

(Street)
EMERYVILLE CA 94608

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
OmniAb, Inc. [ OABI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/17/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/17/2025 M 20,000(1) A (2) 58,333 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (2) 06/17/2025 M 20,000 (1) (1) Common Stock 20,000 $0 26,667 D
Restricted Stock Units (2) 06/17/2025 A 20,000 (3) (3) Common Stock 20,000 $0 46,667 D
Stock Option (right to buy) $1.7 06/17/2025 A 40,000 (4) 06/17/2035 Common Stock 40,000 $0 40,000 D
Explanation of Responses:
1. Represents the vesting of an RSU granted on June 18, 2024, which occurs on the earlier of (A) the date of the next annual meeting of the Company's stockholders following the grant date and (B) the first anniversary of the grant date.
2. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
3. The RSUs shall vest in full on the earlier of (A) the date of the next annual meeting of the Company's stockholders following the grant date and (B) the first anniversary of the grant date.
4. Each Stock Option shall vest and become exercisable in full on the earlier of (A) the date of the next annual meeting of the Company's stockholders following the grant date and (B) the first anniversary of the date of grant.
Remarks:
By: /s/ Charles S. Berkman, Attorney-in-Fact For: Steven Love 06/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many OmniAb (OABI) common shares does Steven Love own after the 17-Jun-2025 transactions?

58,333 shares are now held directly.

What equity grants did Steven Love receive on 17-Jun-2025?

He received 20,000 RSUs and 40,000 stock options at a $1.70 strike price.

Did the Form 4 disclose any open-market sales of OmniAb stock?

No. All reported activities were vesting conversions and new grants; no sales were recorded.

When do the newly granted RSUs and options vest?

Both vest in full on the earlier of OmniAb’s next annual stockholder meeting or one year from grant.

What is the expiration date of the 40,000 stock options granted?

The options expire on 17-Jun-2035.

What transaction code was used for the RSU vesting conversion?

Code M, indicating a conversion of derivative security.
OmniAb, Inc.

NASDAQ:OABI

OABI Rankings

OABI Latest News

OABI Latest SEC Filings

OABI Stock Data

206.75M
98.88M
5.91%
67.65%
6.58%
Biotechnology
Services-commercial Physical & Biological Research
Link
United States
EMERYVILLE